{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:21:51Z","timestamp":1784154111461,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIHR Biomedical Research Centre","award":["reference IS-BRC-1215-20001"],"award-info":[{"award-number":["reference IS-BRC-1215-20001"]}]},{"DOI":"10.13039\/501100014034","name":"Foundation for Research in Rheumatology","doi-asserted-by":"publisher","award":["reference 022"],"award-info":[{"award-number":["reference 022"]}],"id":[{"id":"10.13039\/501100014034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["0800629"],"award-info":[{"award-number":["0800629"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NECESSITY","award":["reference 806975"],"award-info":[{"award-number":["reference 806975"]}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1136\/ard-2023-224503","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T17:25:26Z","timestamp":1693589126000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4238-8651","authenticated-orcid":false,"given":"Joe Scott","family":"Berry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Tarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Casement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1070-8830","authenticated-orcid":false,"given":"Pierre-Marie","family":"Duret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein-Joar","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3829-7431","authenticated-orcid":false,"given":"Gunnel","family":"Nordmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Devauchelle-Pensec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5523-1856","authenticated-orcid":false,"given":"Raphaele","family":"Seror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-549X","authenticated-orcid":false,"given":"Benjamin","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fransesca","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bombardieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Lendrem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-4032","authenticated-orcid":false,"given":"Renaud","family":"Felten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9469-946X","authenticated-orcid":false,"given":"Jacques-Eric","family":"Gottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Fai","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-224503_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23472-7","article-title":"A new molecular classification to drive precision treatment strategies in primary Sj\u00f6gren's syndrome","volume":"12","author":"Soret","year":"2021","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2023-224503_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12967-021-03051-6","article-title":"Longitudinal analysis of symptom-based clustering in patients with primary Sjogren's syndrome: a prospective cohort study with a 5-year follow-up period","volume":"19","author":"Lee","year":"2021","journal-title":"J Transl Med"},{"key":"10.1136\/ard-2023-224503_bib3","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/S2665-9913(19)30042-6","article-title":"Symptom-based stratification of patients with primary Sj\u00f6gren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials","volume":"1","author":"Tarn","year":"2019","journal-title":"Lancet Rheumatology"},{"key":"10.1136\/ard-2023-224503_bib4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00296-021-04927-y","article-title":"Revisiting the JOQUER trial: stratification of primary Sj\u00f6gren's syndrome and the clinical and interferon response to hydroxychloroquine","volume":"41","author":"Collins","year":"2021","journal-title":"Rheumatol Int"},{"issue":"Suppl 1","key":"10.1136\/ard-2023-224503_bib5","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1471-2105-7-S1-S7","article-title":"ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context","volume":"7","author":"Margolin","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1136\/ard-2023-224503_bib6","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/rheumatology\/key438","article-title":"Emerging roles for chemokines and cytokines as orchestrators of immunopathology in Sj\u00f6gren's syndrome","volume":"60","author":"Blokland","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-224503_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000772","article-title":"Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sj\u00f6gren's syndrome and non-autoimmune sicca","volume":"5","author":"Blokland","year":"2019","journal-title":"RMD Open"},{"key":"10.1136\/ard-2023-224503_bib8","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.39315","article-title":"CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sj\u00f6gren's syndrome","volume":"67","author":"Nocturne","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-224503_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/rheumatology\/kez255","article-title":"CXCL13 as biomarker for histological involvement in Sj\u00f6gren's syndrome","volume":"59","author":"Colafrancesco","year":"2020","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2023-224503_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/rheumatology\/ket401","article-title":"CX3Cl1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: Fractalkine contribution to lymphoid neogenesis in Sj\u00f6gren's syndrome","volume":"53","author":"Astorri","year":"2014","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2023-224503_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12662","article-title":"Transcription profiling of peripheral B cells in antibody-positive primary Sj\u00f6gren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature","volume":"87","author":"Imgenberg-Kreuz","year":"2018","journal-title":"Scand J Immunol"},{"key":"10.1136\/ard-2023-224503_bib12","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1177\/09612033211042293","article-title":"Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus","volume":"30","author":"Kunishita","year":"2021","journal-title":"Lupus"},{"key":"10.1136\/ard-2023-224503_bib13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11581","article-title":"Novel Foxo1-dependent transcriptional programs control T reg cell function","volume":"491","author":"Ouyang","year":"2012","journal-title":"Nature"},{"key":"10.1136\/ard-2023-224503_bib14","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni.3230","article-title":"The ubiquitin-specific protease USP8 is critical for the development and homeostasis of T cells","volume":"16","author":"Dufner","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1136\/ard-2023-224503_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107982","article-title":"Stromal cell-contact dependent PI3K and APRIL induced NF-\u039aB signaling prevent Mitochondrial- and ER stress induced death of memory plasma cells","volume":"32","author":"Cornelis","year":"2020","journal-title":"Cell Rep"},{"key":"10.1136\/ard-2023-224503_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29401-6","article-title":"USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy","volume":"13","author":"Xiong","year":"2022","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2023-224503_bib17","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012583","article-title":"Base excision repair","volume":"5","author":"Krokan","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1136\/ard-2023-224503_bib18","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1093\/emboj\/18.20.5609","article-title":"Ref-1 regulates the transactivation and pro-apoptotic functions of P53 in vivo","volume":"18","author":"Gaiddon","year":"1999","journal-title":"EMBO J"},{"key":"10.1136\/ard-2023-224503_bib19","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1074\/jbc.M114.621995","article-title":"Apurinic\/apyrimidinic endonuclease\/redox factor-1 (APE1\/Ref-1) redox function negatively regulates NRF2","volume":"290","author":"Fishel","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1136\/ard-2023-224503_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","article-title":"TIGAR, a P53-inducible regulator of glycolysis and apoptosis","volume":"126","author":"Bensaad","year":"2006","journal-title":"Cell"},{"key":"10.1136\/ard-2023-224503_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/cells9010184","article-title":"A review of FoxO1-regulated metabolic diseases and related drug discoveries","volume":"9","author":"Peng","year":"2020","journal-title":"Cells"},{"key":"10.1136\/ard-2023-224503_bib22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/cells10030634","article-title":"A novel therapeutic target, Bach1, regulates cancer metabolism","volume":"10","author":"Padilla","year":"2021","journal-title":"Cells"},{"key":"10.1136\/ard-2023-224503_bib23","article-title":"Targeting RAGE signaling in inflammatory disease RAGE: receptor for advanced glycation end-products","author":"Hudson","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1136\/ard-2023-224503_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123953","article-title":"Neurological and inflammatory manifestations in Sj\u00f6gren's syndrome: the role of the kynurenine metabolic pathway","volume":"19","author":"de Oliveira","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1136\/ard-2023-224503_bib25","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.neubiorev.2013.06.006","article-title":"The role of COMT gene variants in depression: bridging neuropsychological, behavioral and clinical phenotypes","volume":"37","author":"Antypa","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1136\/ard-2023-224503_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbi.2017.05.013","article-title":"Exogenous FGF2 reverses depressive-like behaviors and restores the suppressed FGF2-ERK1\/2 signaling and the impaired hippocampal neurogenesis induced by neuroinflammation","volume":"66","author":"Tang","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1136\/ard-2023-224503_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01696","article-title":"The role of inflammation in depression and fatigue","volume":"10","author":"Lee","year":"2019","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2023-224503_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2020-218467","article-title":"Interleukin 6 receptor inhibition in primary Sj\u00f6gren syndrome: a multicentre double-blind randomised placebo-controlled trial","volume":"80","author":"Felten","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224503_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030123","article-title":"Interleukin-1 inhibition and fatigue in primary Sj\u00f6gren's syndrome - a double blind, randomised clinical trial","volume":"7","author":"Norheim","year":"2012","journal-title":"PLoS One"},{"key":"10.1136\/ard-2023-224503_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41584-022-00834-z","article-title":"The role of mitochondria in rheumatic diseases","volume":"18","author":"Becker","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2023-224503_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41398-020-01164-y","article-title":"The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill","volume":"11","author":"Knight","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1136\/ard-2023-224503_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/annrheumdis-2017-211836","article-title":"Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"77","author":"Rempenault","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224503_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143970","article-title":"A transcriptional signature of fatigue derived from patients with primary Sj\u00f6gren's syndrome","volume":"10","author":"James","year":"2015","journal-title":"PLoS One"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724003923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724003923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-224503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:45:51Z","timestamp":1737348351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724003923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0003496724003923"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-224503","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-224503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 \u00a9 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}